Ad
related to: bristol-myers squibb
Search results
Bristol Myers Squibb Announces Phase 3 Results Of Opdivo/Yervoy Combo In Liver Cancer Patients -...
Benzinga· 13 hours agoOpdivo plus Yervoy combo shows significant survival benefits and higher response rates vs....
Why Bristol Myers Squibb (BMY) Outpaced the Stock Market Today
Zacks via Yahoo Finance· 1 day agoThe latest trading session saw Bristol Myers Squibb (BMY) ending at $41.77, denoting a +1.65%...
Shareholders in Bristol-Myers Squibb (NYSE:BMY) are in the red if they invested a year ago
Simply Wall St. via Yahoo Finance· 18 hours agoThe simplest way to benefit from a rising market is to buy an index fund. But if you buy individual...
Bristol Myers Squibb’s Breyanzi shows promise in B-cell malignancy clinical trials
Clinical Trials Arena via Yahoo Finance· 19 hours agoUS-based pharmaceutical company Bristol Myers Squibb (BMS) has published data from three studies in...
Rathbones Group PLC Trims Stock Position in Bristol-Myers Squibb (NYSE:BMY)
ETF DAILY NEWS· 21 hours agoRathbones Group PLC reduced its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 24.0% in the 4th quarter, according to its most recent 13F filing with the Securities and ...
Why US Drug Giant Bristol Myers Squibb Stock Trading Up On Monday - Bristol-Myers Squibb (NYSE:BMY)
Benzinga· 2 days agoBristol Myers Squibb & Co BMY announced on Saturday (June 1) results from the Phase 3 KRYSTAL-12...
Bristol-Myers Squibb's Options: A Look at What the Big Money is Thinking - Bristol-Myers Squibb...
Benzinga· 5 days agoLoading... Loading... Deep-pocketed investors have adopted a bearish approach towards Bristol-Myers Squibb BMY , and it's something market players shouldn't ignore. Our tracking of public options ...
Bristol Myers Squibb’s Breyanzi gains FDA approval for lymphoma
Pharmaceutical Technology via Yahoo Finance· 5 days agoBristol Myers Squibb (BMS) has received approval from the US Food and Drug Administration for...
Bristol-Myers Squibb Co. [BMY] Investment Appeal on the Rise – Knox Daily
Knox Daily· 7 days agoBristol-Myers Squibb Co.’s filing revealed that its Chief Executive Officer BOERNER CHRISTOPHER S. acquired Company’s shares for reported $99560.0 on Dec 05 ’23. In the deal valued at $49.78 ...
Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 6 days agoBristol Myers (BMY) has received quite a bit of attention from Zacks.com users lately. Therefore, it...